SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-14-179407
Filing Date
2014-05-02
Accepted
2014-05-02 12:15:41
Documents
11
Period of Report
2014-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q d699449d10q.htm 10-Q 779704
2 EX-10.1 d699449dex101.htm EX-10.1 129337
3 EX-31.1 d699449dex311.htm EX-31.1 8352
4 EX-31.2 d699449dex312.htm EX-31.2 8379
5 EX-32.1 d699449dex321.htm EX-32.1 3116
  Complete submission text file 0001193125-14-179407.txt   7992901

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT bmrn-20140331.xml EX-101.INS 1364255
7 XBRL TAXONOMY EXTENSION SCHEMA bmrn-20140331.xsd EX-101.SCH 57322
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE bmrn-20140331_cal.xml EX-101.CAL 108135
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE bmrn-20140331_def.xml EX-101.DEF 408809
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE bmrn-20140331_lab.xml EX-101.LAB 511099
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE bmrn-20140331_pre.xml EX-101.PRE 478441
Mailing Address 105 DIGITAL DRIVE NOVATO CA 94949
Business Address 105 DIGITAL DRIVE NOVATO CA 94949 4155066700
BIOMARIN PHARMACEUTICAL INC (Filer) CIK: 0001048477 (see all company filings)

IRS No.: 680397820 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-26727 | Film No.: 14808010
SIC: 2834 Pharmaceutical Preparations